Glucagon-like Peptide-1 Receptor Agonists and Pancreatic Cancer Risk: Balancing Reassurance and Vigilance
12 Aug 2026, 4 p.m.
Publication date: Available online 11 August 2026Source: PancreatologyAuthor(s): Jianing Li, ...
Pancreatology Journal, latest articles
Systemic Inflammation Response Index (SIRI) predicts outcomes and chemotherapy benefit in metastatic pancreatic cancer: A study by the PANTHEIA- SEOM group
12 Aug 2026, 4 p.m.
Publication date: Available online 11 August 2026Source: PancreatologyAuthor(s): Alberto Carmona-Bayonas, ...
Induction of Acute Pancreatitis in Adult Zebrafish: A Reproducible and Quantifiable Experimental Model
12 Aug 2026, 4 p.m.
Publication date: Available online 12 August 2026Source: PancreatologyAuthor(s): Prince Allawadhi, ...
DIAGNOSIS AND FOLLOW-UP OF IPMNS OF THE PANCREAS – BRINGING THE ETHICAL ISSUES INTO FOCUS
11 Aug 2026, 7 p.m.
Publication date: Available online 10 August 2026Source: PancreatologyAuthor(s): Alberto Balduzzi, ...
Intratumoral Microbiota in Pancreatic Neuroendocrine Tumors: Enriched Bacterial Biomass and Diversity with Association to Dyslipidemia
7 Aug 2026, 1 p.m.
Publication date: Available online 6 August 2026Source: PancreatologyAuthor(s): Yu-Fan Meng, ...
Hypertriglyceridaemia-Induced Acute Pancreatitis in Tunisia: Predictors of Severity and Early Recurrence from a North African Cohort
5 Aug 2026, 6 p.m.
Publication date: Available online 4 August 2026Source: PancreatologyAuthor(s): Imen Ben ...
Baseline Current Smoking and Time-Varying Recurrence Risk After First-Episode of Hypertriglyceridemia-Induced Acute Pancreatitis: A Multicenter Retrospective Cohort Study
5 Aug 2026, 6 p.m.
Publication date: Available online 4 August 2026Source: PancreatologyAuthor(s): Jianying Liu, ...
Clinical outcomes and cost-effectiveness of surveillance for asymptomatic pancreatic head cystic neoplasms in adults aged 40–75: a microsimulation study
4 Aug 2026, 5 p.m.
Publication date: Available online 3 August 2026Source: PancreatologyAuthor(s): Ailing Gong, ...
News (September 2020)
COVIDSurg-Cancer paper accepted by JCO
14th Sep 2020
We are delighted to announce that COVIDSurg-Cancer paper accepted by JCO (impact factor 33), and would like to thank AUGIS/GBIHPBA for their support of the study. read more..